Porphyrinuria in childhood autistic disorder is not associated with urinary creatinine deficiency

Pediatrics International

Volumn 50, Issue 4, 2008, Pages 528-532

  Nataf, Robert ^a   Skorupka, Corinne ^b   Lam, Alain ^a   Springbett, Anthea ^c   Lathe, Richard ^d  

^a Laboratoire Philippe Auguste   (France)

^b Association ARIANE   (France)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d Pieta Research   (United Kingdom)

Author keywords

Autism; Creatinine; Pervasive developmental disorder; Porphyrin; Urine

Indexed keywords

COPROPORPHYRIN; CREATININE; ISOPROSTANE DERIVATIVE; PORPHYRIN;

ABNORMAL URINE COMPOSITION; ADOLESCENT; AGE; ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; PORPHYRINURIA; PRIORITY JOURNAL; SAMPLING ERROR; URINALYSIS;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CREATININE; FEMALE; HUMANS; MALE; PORPHYRINS;

EID: 50249098112     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02621.x     Document Type: Article

References (48)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). American Psychiatric Association, Washington, DC, 1994.
2. WHO. The ICD-10 Classification of Mental and Behavioural Disorders. World Health Organization, Geneva, 1992.
3. Wing L. Autistic spectrum disorders. Br. Med. J. 1996 312 : 327 8.
4. Gillberg C, Coleman M. The Biology of the Autistic Syndromes, 3rd edn. MacKeith-Cambridge University Press, Cambridge, 2000.
5. Hanley HG, Stahl SM, Freedman DX. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch. Gen. Psychiatry 1977 34 : 521 31.
6. Anderson GM, Freedman DX, Cohen DJ et al. Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiatry 1987 28 : 885 900.
7. Modahl C, Green L, Fein D et al. Plasma oxytocin levels in autistic children. Biol. Psychiatry 1998 43 : 270 77.
8. Strous RD, Golubchik P, Maayan R et al. Lowered DHEA-S plasma levels in adult individuals with autistic disorder. Eur. Neuropsychopharmacol. 2005 15 : 305 9.
9. Tordjman S, Ferrari P, Sulmont V, Duyme M, Roubertoux P. Androgenic activity in autism. Am. J. Psychiatry 1997 154 : 1626 7.
10. Richdale AL, Prior MR. Urinary cortisol circadian rhythm in a group of high-functioning children with autism. J. Autism Dev. Disord. 1992 22 : 433 47.
11. Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 2006 66 : 182 8.
12. James SJ, Cutler P, Melnyk S et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004 80 : 1611 17.
13. James SJ, Melnyk S, Jernigan S et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006 141 : 947 56.
14. Lathe R. Autism, Brain, and Environment. Jessica Kingsley Publishers, London, 2006.
15. Björkman L, Vahter M. Comment on: "A cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production" by Heyer et al. Toxicol. Lett. 2007 169 : 91 2.
16. Vahter M, Björkman L, Goessler W. Concentrations of biomarkers in spot urine samples need adjustment for variation in dilution - Comment on: "Distribution of urinary selenium and arsenic among pregnant women exposed to arsenic in drinking water" by Christian et al. Environ. Res. 2007 104 : 312 13.
17. Heyer NJ, Bittner AC. Jr., Echeverria D, Woods JS. Response to: "Comment on a cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production" by Björkman et al. Toxicol. Lett. 2007 169 : 93 4.
18. Edwards KDG, Whyte HM. Creatinine excretion and body composition. Clin. Sci. 1959 18 : 361 6.
19. Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am. J. Clin. Nutr. 1976 29 : 1359 66.
20. Trowbridge FL, Hiner CD, Robertson AD. Arm muscle indicators and creatinine excretion in children. Am. J. Clin. Nutr. 1982 36 : 691 6.
21. Remer T, Neubert A, Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am. J. Clin. Nutr. 2002 75 : 561 9.
22. Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R. Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity. Toxicol. Appl. Pharmacol. 2006 214 : 99 108.
23. Yao Y, Walsh WJ, McGinnis WR, Pratico D. Altered vascular phenotype in autism: Correlation with oxidative stress. Arch. Neurol. 2006 63 : 1161 4.
24. Whiteley P, Waring R, Williams L et al. Spot urinary creatinine excretion in pervasive developmental disorders. Pediatr. Int. 2006 48 : 292 7.
25. Wallace WHB, Green DME. Late Effects of Childhood Cancer. Arnold, London, 2004.
26. Katoda H. Height and weight of Tokyo schoolchildren with and without intellectual handicaps. Ann. Hum. Biol. 1991 18 : 327 39.
27. Mouridsen SE, Rich B, Isager T. Body mass index in male and female children with infantile autism. Autism 2002 6 : 197 205.
28. Bolte S, Ozkara N, Poustka F. Autism spectrum disorders and low body weight: Is there really a systematic association? Int. J. Eat. Disord. 2002 31 : 349 51.
29. Whiteley P, Dodou K, Todd L, Shattock P. Body mass index of children from the United Kingdom diagnosed with pervasive developmental disorders. Pediatr. Int. 2004 46 : 531 3.
30. Curtin C, Bandini LG, Perrin EC, Tybor DJ, Must A. Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: A chart review. BMC Pediatr. 2005 5 : 48.
31. Wright B, Brzozowski AM, Calvert E et al. Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder? Dev. Med. Child Neurol. 2005 47 : 190 92.
32. Geier DA, Geier MR. A prospective assessment of porphyrins in autistic disorders: A potential marker for heavy metal exposure. Neurotox. Res. 2006 10 : 57 64.
33. Salomons GS, van Dooren SJ, Verhoeven NM et al. X-linked creatine transporter defect: An overview. J. Inherit. Metab. Dis. 2003 26 : 309 18.
34. Clark AJ, Rosenberg EH, Almeida LS et al. X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum. Genet. 2006 119 : 604 10.
35. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005 113 : 192 200.
36. Rubin RT. Urine creatinine excretion: Variability and volume dependency during sleep deprivation. Psychosom. Med. 1971 33 : 539 543.
37. Martin MD, McCann T, Naleway C, Woods JS, Leroux BG, Bollen AM. The validity of spot urine samples for low-level occupational mercury exposure assessment and relationship to porphyrin and creatinine excretion rates. J. Pharmacol. Exp. Ther. 1996 277 : 239 44.
38. Woods JS, Martin MD, Leroux BG. Validity of spot urine samples as a surrogate measure of 24-hour porphyrin excretion rates. Evaluation of diurnal variations in porphyrin, mercury, and creatinine concentrations among subjects with very low occupational mercury exposure. J. Occup. Environ. Med. 1998 40 : 1090 1101.
39. Vaziri ND, Byrne C, Ryan G, Wilson A. Preservation of urinary postprandial alkaline tide despite inhibition of gastric acid secretion. Am. J. Gastroenterol. 1980 74 : 328 31.
40. Johnson CD, Mole DR, Pestridge A. Postprandial alkaline tide: Does it exist? Digestion 1995 56 : 100 06.
41. Niv Y, Fraser GM. The alkaline tide phenomenon. J. Clin. Gastroenterol. 2002 35 : 5 8.
42. Woods JS. Altered porphyrin metabolism as a biomarker of mercury exposure and toxicity. Can. J. Physiol Pharmacol. 1996 74 : 210 15.
43. Daniell WE, Stockbridge HL, Labbe RF et al. Environmental chemical exposures and disturbances of heme synthesis. Environ. Health Perspect. 1997 105 (Suppl. 1 37 53.
44. Bradstreet J. A case control study of mercury burden in children with autistic spectrum disorders. J. Am. Phys. Surg. 2003 8 : 76 79.
45. Adams JB, Romdalvik J, Ramanujam VM, Legator MS. Mercury, lead, and zinc in baby teeth of children with autism versus controls. J. Toxicol. Environ. Health A 2007 70 : 1046 51.
46. Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int. J. Toxicol. 2003 22 : 277 85.
47. Kern JK, Grannemann BD, Trivedi MH, Adams JB. Sulfhydryl-reactive metals in autism. J. Toxicol. Environ. Health A 2007 70 : 715 21.
48. Chen C, Qu L, Li B et al. Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2'-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clin. Chem. 2005 51 : 759 67.